Tirzepatide acts on both the GIP and GLP-1 receptors.
Weight loss
Zepbound®Rx
tirzepatide for weight loss
4.8 average rating (placeholder)
Starting at $999/mo
Monthly supply: $999 first month, then $999
Klarna — pay in 4 (placeholder)Afterpay (placeholder) FSA/HSA eligible
- Dual receptor actionTirzepatide acts on both the GIP and GLP-1 receptors.
- Defined scheduleDosing follows the labeled monthly escalation steps.
- Licensed dispensingFilled by United States pharmacies with cold-chain shipping.
FSA & HSA eligibleIn stock
Quick answers
- Is tirzepatide stronger than semaglutide?
- They work through different receptor targets and are not directly interchangeable. Your provider weighs tolerance, history, and goals rather than potency alone.
- How is it stored?
- Refrigerate as directed on the label and keep it away from light. Storage instructions ship with every order.
- How do I know if Zepbound is right for me?
- You start with an online intake covering your health history, current medications, and goals. A licensed provider reviews it and decides whether this medication is appropriate, suggests an alternative, or recommends you speak with your primary care team first.
Related treatments
Provider reviewed Free expedited shipping
Zepbound® is a registered trademark of its manufacturer, which is not affiliated with Salara Life.
These statements have not been evaluated by the Food and Drug Administration. Compounded medications are not FDA-approved. This product is not intended to diagnose, treat, cure, or prevent any disease, and a prescription is issued only after a licensed provider reviews your intake.
The basics
A closer look at Zepbound®
Brand tirzepatide for chronic weight management, dispensed when a licensed provider determines it is clinically appropriate for you.
It suits people who want a structured, supervised approach rather than a quick fix. Your provider sets the starting point, watches how you respond, and adjusts the plan at a pace your body can handle.
Rooted in science
Why clinicians reach for it
Dual receptor action
Tirzepatide acts on both the GIP and GLP-1 receptors.
Defined schedule
Dosing follows the labeled monthly escalation steps.
Licensed dispensing
Filled by United States pharmacies with cold-chain shipping.
Benefits
What members notice
Dosing follows the labeled monthly escalation steps.
Filled by United States pharmacies with cold-chain shipping.
Tirzepatide acts on both the GIP and GLP-1 receptors.
Ready when you are.
A free eligibility check takes a few minutes and there is no obligation.
Get started
Evidence
What the research shows
- Tirzepatide is a dual GIP and GLP-1 receptor agonist given once weekly.
- Studies pair treatment with structured lifestyle changes.
- Nausea and reduced appetite are frequently reported early in titration.
- Your provider reassesses the plan as your dose increases.
Research summaries are educational and do not imply guaranteed outcomes.
How it works
From intake to ongoing care
01Submit your application and meet a doctor
Complete a short online intake, then connect with a licensed clinician who reviews your history and goals.
02Get your medication delivered at home
If treatment is appropriate, a U.S. pharmacy prepares your prescription and ships it discreetly at no extra cost.
03Receive 24/7 support and ongoing care
Message your care team any time and adjust the plan as your body responds month to month.
Treatment works best when it is matched to the person in front of you, not to a trend. We start conservatively, watch closely, and adjust only when the response tells us to.
Included
All plans include
- 1-on-1 guidance from your care team
- No-cost consultations with a licensed provider
- Free expedited 2-day shipping
- All supplies included with every refill
- Patient education materials written in plain language
- Ongoing team support between refills
Membership renews automatically until you cancel. Cancel any time before your next refill ships; medication is only sent when a provider has approved it.
Reviews
What members say
“The intake was straightforward and the provider actually explained why this treatment made sense for me.”
“Shipping was faster than I expected and everything arrived cold and intact.”
“I appreciated that the care team checked in before my second month instead of waiting for me to ask.”
“Pricing was clear from the start. No surprise charges when the refill came around.”
“A few weeks in and I feel steady. This treatment has been easy to keep up with.”
“Support answered my question the same day and adjusted my schedule without any friction.”
Individual results may vary.
Questions
Frequently asked
They work through different receptor targets and are not directly interchangeable. Your provider weighs tolerance, history, and goals rather than potency alone.
Keep exploring
You may also be interested in
GLP-1 Weight Loss TreatmentsRx
for weight loss
From $99/mo
Wegovy®Rx
semaglutide for weight loss
From $999/mo
Mounjaro®Rx
tirzepatide injection
From $999/mo
Custom Weight Loss KitRx
your complete program
From $149/mo
Availability of any treatment depends on your intake, your state, and the judgment of a licensed provider. Prices shown are starting points and may change based on the plan and dose your provider recommends.
Get started
Zepbound®Rx
First month from $999
- No long-term contracts
- Personalized plans
- On-demand medical support
- Free expedited shipping
Membership renews automatically until cancelled. You are only charged for a refill after a provider approves it.
Disclaimer
This is a third-party brand name product. Salara Life is not affiliated with, endorsed by, or sponsored by the trademark holder.
A prescription is issued only after a consultation with a licensed provider who determines it is appropriate for you.
Medications are prepared and dispensed by licensed pharmacies in the United States.
This page is educational and is not medical advice. Talk with your provider about possible side effects, interactions, and whether treatment is right for you.
Supporting studies
- Placeholder citation. Journal of Metabolic Practice. Review of incretin-based therapy outcomes. 2023.
- Placeholder citation. Clinical Endocrinology Reports. Dose titration and tolerability in outpatient care. 2022.
- Placeholder citation. American Review of Preventive Medicine. Lifestyle adjuncts to pharmacotherapy. 2024.
- Placeholder citation. Peptide Therapeutics Quarterly. Safety monitoring in compounded preparations. 2023.
- Placeholder citation. Journal of Pharmacy Compounding Standards. Sterility and potency testing methods. 2021.